Sugi Predict

Sugi Predict / Compounds / SCHEMBL19106203

SCHEMBL19106203

SCHEMBL19106203

c1ccc(-c2nc(-c3ccc(-c4nc(-c5ccc6ccccc6c5)nc(-c5cc6ccccc6cn5)n4)cc3)nc3c2sc2ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.35
▸ ADORA1 P30542 2/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ ATM Q13315 1/20 0.34
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TNKS O95271 2/20 0.32
▸ TNKS2 Q9H2K2 2/20 0.32
▸ KRAS P01116 1/20 0.32
▸ LIMK1 P53667 3/20 0.31
▸ MAPT P10636 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106194 0.90 MEN1 (0.41) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL19106197 0.90 MEN1 (0.41) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL19106260 0.89 LIMK1 (0.35) MEN1KMT2AATMNPC1RAB9A
SCHEMBL16902377 0.88 ADORA2A (0.39) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL19106285 0.87 LIMK1 (0.35) MEN1KMT2AATMNPC1RAB9A
SCHEMBL16902380 0.85 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL16902307 0.85 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL19106283 0.84 CYP1A1 (0.40) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL16581198 0.83 MEN1 (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18018401 0.83 LIMK1 (0.37) ADORA2AADORA1MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 ADORA2A 4441/4885ADORA1 4054/4885MEN1 1003/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 ADORA2A 4441/4885ADORA1 4054/4885MEN1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback